Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Chemistry

formerly Central European Journal of Chemistry


IMPACT FACTOR 2017: 1.425
5-year IMPACT FACTOR: 1.511

CiteScore 2018: 1.58

SCImago Journal Rank (SJR) 2018: 0.345
Source Normalized Impact per Paper (SNIP) 2018: 0.684

ICV 2017: 165.27

Open Access
Online
ISSN
2391-5420
See all formats and pricing
More options …
Volume 10, Issue 1

Issues

Volume 13 (2015)

Development and validation of the stability-indicating LC-UV method for the determination of cefoselis sulphate

Przemysław Zalewski / Judyta Cielecka-Piontek / Anna Jelińska
Published Online: 2011-11-24 | DOI: https://doi.org/10.2478/s11532-011-0112-9

Abstract

The stability-indicating LC assay method was developed and validated for quantitative determination of cefoselis sulphate in the presence of degradation products formed during the forced degradation studies. An isocratic, RP-HPLC method was developed with C-18 (250 × 4.6 mm, 5 µm) column and 12 mM ammonium acetate-acetonitrile (95:5 V/V) as a mobile phase. The flow rate of the mobile phase was 1.0 mL min−1. Detection wavelength was 260 nm and temperature was 30°C. Cefoselis similarly to other cephalosporins was subjected to stress conditions of degradation in aqueous solutions including hydrolysis, oxidation, photolysis and thermal degradation. The developed method was validated with regard to linearity, accuracy, precision, selectivity and robustness. The method was applied successfully for identification and determination of cefoselis sulphate in pharmaceuticals and during kinetic studies.

Keywords: Method validation; Stability-indicating method; Cefoselis sulphate

  • [1] T. Kuriyama, T. Karasawa, K. Nakagawa, S. Nakamura, E. Yamamoto, Oral Microbiol. Immunol. 17, 285 (2002) http://dx.doi.org/10.1034/j.1399-302X.2002.170504.xCrossrefGoogle Scholar

  • [2] M.W. Climo, S.M. Markowitz, D.S. Williams, C.G. Hale-Cooper, G.L. Archer, J. Antimicrob. Chemother. 40, 59 (1997) http://dx.doi.org/10.1093/jac/40.1.59CrossrefGoogle Scholar

  • [3] H.C. Neu, N.X. Chin, H.B. Huang, Antimicrob Agents Chemother 37(3), 566 (1993) CrossrefGoogle Scholar

  • [4] G. Patel, S. Rajput, Acta Chromatogr. 23(2), 215 (2011) http://dx.doi.org/10.1556/AChrom.23.2011.2.3CrossrefGoogle Scholar

  • [5] Y. Ikeda, J. Ban, T. Ishikawa, S. Hashiguchi, S. Urayama, H. Horibe, Chem. Pharm. Bull. 56(10), 1406 (2008) http://dx.doi.org/10.1248/cpb.56.1406CrossrefGoogle Scholar

  • [6] A. Jelińska, L. Dobrowolski, I. Oszczapowicz, J. Pharm. Biomed. Anal. 35(5), 1273 (2004) http://dx.doi.org/10.1016/j.jpba.2004.03.017CrossrefGoogle Scholar

  • [7] T. Sugioka, T. Asano, Y. Chikaraishi, E. Suzuki, A. Sano, T. Kuriki, M. Shirotsuka, K. Saito, Chem. Pharm. Bull. 38(7), 1998 (1990) http://dx.doi.org/10.1248/cpb.38.1998CrossrefGoogle Scholar

  • [8] J.O. Fubara, R.E. Notari, J. Pharm. Sci. 87(12), 1572 (1998) http://dx.doi.org/10.1021/js980170yCrossrefGoogle Scholar

  • [9] B. Medenecka, A. Jelińska, M. Zając, M. Bałdyka, K. Juszkiewicz, I. Oszczapowicz, Acta Pol. Pharm. 66(5), 563 (2009) PubMedGoogle Scholar

  • [10] A. Jelińska, B. Medenecka, M. Zając, M. Knajsiak, Acta Pol. Pharm. 65(2), 261 (2008) PubMedGoogle Scholar

  • [11] M. Zając, A. Jelińska, P. Zalewski, Acta Pol. Pharm. 62(2), 89 (2005) PubMedGoogle Scholar

  • [12] A. Jelińska, I. Dudzińska, M. Zając, I. Oszczapowicz, W. Krzewski Acta Pol. Pharm. 62(3)183 (2005) PubMedGoogle Scholar

  • [13] M. Zając, A. Jelińska, L. Dobrowolski, I. Oszczapowicz, J. Pharm. Biomed. Anal. 32(6), 1181 (2003) http://dx.doi.org/10.1016/S0731-7085(03)00237-1CrossrefGoogle Scholar

  • [14] A. Jelińska, M. Zając, J. Gostomska, M. Szczepaniak, Farmaco 58(4), 309 (2003) http://dx.doi.org/10.1016/S0014-827X(02)00023-XCrossrefGoogle Scholar

  • [15] A. Jelińska, M. Zając, M. Jakubowska, React. Kinet. Catal. Lett. 73(2), 325 (2001) http://dx.doi.org/10.1023/A:1014175710690CrossrefGoogle Scholar

  • [16] J. Cielecka-Piontek, K. Michalska, P. Zalewski, A. Jelińska, Curr. Pharm. Anal. 7(4), 213 (2011) Google Scholar

  • [17] K. Ohtaki, K. Matsubara, S. Fujimaru, K. Shimizu, T. Awaya, M. Suno, K. Chiba, N. Hayase, H. Shiono, J. Neural. Transm. 111, 1523 (2004) http://dx.doi.org/10.1007/s00702-004-0177-0CrossrefGoogle Scholar

  • [18] H. Ueo, H. Motohashi, T. Katsura, K. Inui, Biochemical Pharmacology 70, 1104 (2005) http://dx.doi.org/10.1016/j.bcp.2005.06.024CrossrefGoogle Scholar

  • [19] M. Nagata, M. Yasuhara, Biol. Pharm. Bull. 24(9), 1049 (2001) http://dx.doi.org/10.1248/bpb.24.1049CrossrefGoogle Scholar

  • [20] ICH Q2B, Validation of Analytical Procedures, Methodology, International Conference on Harmonization (IFPMA, Geneva, 2000) Google Scholar

  • [21] M. Bakshi, B. Singh, A. Singh, S. Singh, J. Pharm. Biomed. Anal. 26, 891 (2001) http://dx.doi.org/10.1016/S0731-7085(01)00475-7CrossrefGoogle Scholar

  • [22] M. Bakhi, S. Singh, J. Pharm. Biomed. Anal. 28, 1011 (2002) http://dx.doi.org/10.1016/S0731-7085(02)00047-XCrossrefGoogle Scholar

  • [23] R. Sehrawat, M. Maithani, R. Singh, Chromatographia 72, 1 (2010) http://dx.doi.org/10.1365/s10337-010-1612-zCrossrefGoogle Scholar

About the article

Published Online: 2011-11-24

Published in Print: 2012-02-01


Citation Information: Open Chemistry, Volume 10, Issue 1, Pages 121–126, ISSN (Online) 2391-5420, DOI: https://doi.org/10.2478/s11532-011-0112-9.

Export Citation

© 2011 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Przemysław Zalewski, Robert Skibiński, Daria Szymanowska-Powałowska, Hanna Piotrowska, Maciej Kozak, Zuzanna Pietralik, Waldemar Bednarski, and Judyta Cielecka-Piontek
Journal of Pharmaceutical and Biomedical Analysis, 2016, Volume 118, Page 410
[2]
Piotr Garbacki, Przemysław Zalewski, Robert Skibiński, Maciej Kozak, Magdalena Ratajczak, Kornelia Lewandowska, Waldemar Bednarski, Agnieszka Podborska, Mikołaj Mizera, Anna Jelińska, and Judyta Cielecka-Piontek
X-Ray Spectrometry, 2015, Volume 44, Number 5, Page 344
[3]
Przemysław Zalewski, Robert Skibiński, Magdalena Paczkowska, Piotr Garbacki, Alicja Talaczyńska, Judyta Cielecka-Piontek, and Anna Jelińska
Drug Development and Industrial Pharmacy, 2015, Page 1
[4]
Przemysław Zalewski, Robert Skibiński, Alicja Talaczyńska, Magdalena Paczkowska, Piotr Garbacki, and Judyta Cielecka-Piontek
Journal of Pharmaceutical and Biomedical Analysis, 2015, Volume 114, Page 222
[5]
Przemysław Zalewski, Robert Skibiński, and Judyta Cielecka-Piontek
Journal of Pharmaceutical and Biomedical Analysis, 2014, Volume 92, Page 22
[7]
Przemysław Zalewski, Judyta Cielecka-Piontek, and Anna Jelińska
Reaction Kinetics, Mechanisms and Catalysis, 2013, Volume 108, Number 2, Page 285
[8]
Przemysław Zalewski, Judyta Cielecka-Piontek, Piotr Garbacki, Anna Jelińska, and Marta Karaźniewicz-Łada
Chromatographia, 2013, Volume 76, Number 7-8, Page 387

Comments (0)

Please log in or register to comment.
Log in